Evidence map›Paper›PMID 35367458›Full record

SynthesisIndian heart journal

Meta-analysis of ProGlide versus MANTA vascular closure devices for large-bore access site management.

Gauranga Mahalwar, Mariam Shariff, Sanjana Datla, Ankit Agrawal, Sawai Singh Rathore, Taha Bin Arif, Kinza Iqbal, Nabeel Hussain, Monil Majmundar, Ashish Kumar and 1 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Meta-analysis: percutaneous versus surgical VA-ECMO decannulation demonstrates no clear differences in most outcomes, with a signal toward lower infection.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026
    Pooled it
  2. Suture-based versus plug-based closure for large-bore arterial access: an individual patient-level meta-analysis of randomised trials.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gauranga MahalwarDepartment of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.
Mariam ShariffDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Sanjana DatlaNortheast Ohio Medical University, Ohio, USA.
Ankit AgrawalCleveland Clinic Foundation, Cleveland, OH, USA.
Sawai Singh RathoreDepartment of Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.
Taha Bin ArifDepartment of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Kinza IqbalDepartment of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Nabeel HussainSaba University School of Medicine, The Bottom, the Netherlands.
Monil MajmundarDepartment of Cardiology, Maimonides Medical Center, Brooklyn, NYC, NY, USA.
Ashish KumarDepartment of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.
Ankur KalraDivision of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: ankalra@iu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe comparative effectiveness of ProGlide® compared with MANTA® vascular closure devices (VCDs) in large-bore access site management is not entirely certain, and has only been evaluated in underpowered studies. This meta-analysis aimed to evaluate the outcomes of ProGlide® compared with MANTA® VCDs.

methodsPubMed, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched systematically for relevant articles from the inception of the database until August 27, 2021. The outcomes of interest were all bleeding events, major bleeding, major and minor vascular complications, pseudoaneurysm, stenosis or dissection, and VCD failure. Risk ratios were used as point estimates of endpoints. All statistical analyses were carried out using R version 4.0.3.

resultsFour observational studies and 1 pilot randomized controlled trial (RCT) were included in the final analysis. There was no significant difference between the ProGlide® and MANTA® groups in the risk of all bleeding events, major/life-threatening bleeding, major vascular complications, minor vascular complications, pseudoaneurysms, and/or stenosis or dissection of the entry site vessel. However, the incidence of VCD failure was higher in the ProGlide® group compared with the MANTA® group (RR 1.94; 95% CI 1.31-2.84; I

conclusionIn conclusion, both VCDs (ProGlide® and MANTA®) have comparable outcomes with regard to risk of bleeding, vascular complications, pseudoaneurysms, and/or stenosis or dissection of entry vessel. ProGlide® was however associated with higher device failure.

Indexed as

Aneurysm, FalseVascular Closure DevicesConstriction, PathologicFemoral ArteryHemorrhageHemostatic TechniquesHumansTreatment OutcomeLarge bore accessMANTA®ProGlide®TAVRTransfemoral

Identifiers

PMID35367458
PMCPMC9243605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.